Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs

Disclaimer: The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Acknowledgment: The authors thank Cecily Campbell, JD, LLM (ORISE Fellow, Division of Viral Hepatitis, Centers for Disease Control and Prevention), and the Center for Health Law and Policy Innovation at Harvard Law School for providing their expert knowledge of Medicaid law and structure.

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-0320.

Requests for Single Reprints: Lauren A. Canary, MPH, Division of Viral Hepatitis, National Foundation for the Centers for Disease Control and Prevention, Mailstop G-37, Atlanta, GA 30329; e-mail, lcanary@cdc.gov.

Current Author Addresses: Ms. Canary: Division of Viral Hepatitis, National Foundation for the Centers for Disease Control and Prevention, Mailstop G-37, Atlanta, GA 30329.

Dr. Klevens: Centers for Disease Control and Prevention, 12 Corporate Square Boulevard, Atlanta, GA 30329.

Dr. Holmberg: Division of Viral Hepatitis, Mailstop G-37, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333.

Author Contributions:Conception and design: L.A. Canary.

Analysis and interpretation of the data: L.A. Canary, M. Klevens, S.D. Holmberg.

Drafting of the article: L.A. Canary, S.D. Holmberg.

Critical revision of the article for important intellectual content: M. Klevens, S.D. Holmberg.

Final approval of the article: M. Klevens, S.D. Holmberg.

Obtaining of funding: M. Klevens, S.D. Holmberg.

Administrative, technical, or logistic support: S.D. Holmberg.

Collection and assembly of data: L.A. Canary.